This week in transparency news: February 8 – February 21, 2020

by Staff writer,
Posted on 2/21/2020

Transparency in clinical trials is continually changing, and to stay on top of the news, TrialAssure brings a bi-weekly round-up of some of the key stories. This week’s stories are as follows:

Sponsors of clinical trials may report data late or never – Spectrum News

Despite government action, majority of clinical trial sponsors do not disclose their data to ClinicalTrials.gov. To address this information gap, a team of researchers developed TrialsTracker, a public database that keeps track of the data-reporting compliance of registered trials.

Emily Anthes has the full story

Revealed: how drug giants can access your health records – The Guardian

Leading experts claim that the UK’s Department of Health and Social Care is selling medical data of NHS patients to drug companies without properly anonymizing the data. Senior NHS officials are raising concerns about this situation.

Read Toby Helm’s piece

The Pharma sector must heed the NHS’s warning shot over patient group transparencyPRWeek

In this opinion piece, the authors claim that today’s pharmaceutical companies must be aware of how their behaviors are perceived in wider society, politics, and the healthcare industry. They argue that full transparency with patients groups is critical.

Read the full article by Stephen Day and Ann Bartling

EudraCT Public Web Report for January 2020—European Medicines Agency

The European Medicines Agency released its monthly web report. The report found that a total of 59,126 clinical trials are recorded in the EudraCT database.

Read the entire report here

Share: